Published in Proc Natl Acad Sci U S A on October 01, 1980
A mutation in human CMP-sialic acid hydroxylase occurred after the Homo-Pan divergence. Proc Natl Acad Sci U S A (1998) 3.26
State of hepatitis B virus DNA in hepatocytes of patients with hepatitis B surface antigen-positive and -negative liver diseases. Proc Natl Acad Sci U S A (1981) 2.37
Comparative sequencing of human and chimpanzee MHC class I regions unveils insertions/deletions as the major path to genomic divergence. Proc Natl Acad Sci U S A (2003) 1.43
Monoclonal radioimmunoassays for hepatitis B surface antigen: demonstration of hepatitis B virus DNA or related sequences in serum and viral epitopes in immune complexes. Proc Natl Acad Sci U S A (1982) 1.23
Hepatitis B virus DNA in Kaposi sarcoma. Proc Natl Acad Sci U S A (1983) 0.99
Animal model of human disease. Chimpanzee carriers of hepatitis B virus. Chimpanzee hepatitis B carriers. Am J Pathol (1981) 0.85
Modeling hepatitis B virus infection, immunopathology and therapy in mice. Antiviral Res (2015) 0.79
Hepatitis B virus infection. Current concepts of chronicity and immunity. West J Med (1984) 0.78
Hepatitis B virus molecular biology and pathogenesis. Hepatoma Res (2016) 0.75
Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I. J Mol Biol (1977) 205.11
Method for detection of specific RNAs in agarose gels by transfer to diazobenzyloxymethyl-paper and hybridization with DNA probes. Proc Natl Acad Sci U S A (1977) 40.24
Hepatitis B virus genes and their expression in E. coli. Nature (1979) 10.83
Nucleotide sequence of the gene coding for the major protein of hepatitis B virus surface antigen. Nature (1979) 6.10
Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association. Prog Med Virol (1978) 5.02
Cloning in Escherichia coli and physical structure of hepatitis B virion DNA. Proc Natl Acad Sci U S A (1979) 4.71
Hepatitis and leukemia: their relation to Australia antigen. Bull N Y Acad Med (1968) 4.28
Cloning and endonuclease mapping of the hepatitis B viral genome. Nature (1979) 3.62
A sign inversion mechanism for enzymatic supercoiling of DNA. Science (1979) 3.31
Staining methods of Australia antigen in paraffin section--detection of cytoplasmic inclusion bodies. Jpn J Exp Med (1974) 3.08
Isolation, characterization, and comparison of recombinant DNAs derived from genomes of human hepatitis B virus and woodchuck hepatitis virus. Proc Natl Acad Sci U S A (1980) 3.04
Expression in Escherichia coli of hepatitis B virus DNA sequences cloned in plasmid pBR322. Nature (1979) 3.03
Pattern of core and surface expression in liver tissue reflects state of specific immune response in hepatitis B. Lab Invest (1975) 2.97
Identification of integrated hepatitis B virus DNA and expression of viral RNA in an HBsAg-producing human hepatocellular carcinoma cell line. Nature (1980) 2.72
Transmission of type B viral hepatitis to chimpanzees. J Infect Dis (1973) 2.51
State of hepatitis B viral DNA in a human hepatoma cell line. J Virol (1980) 2.02
DNA synthesized in the hepatitis B Dane particle DNA polymerase reaction. J Virol (1977) 1.92
Recent advances in the study of the epidemiology of hepatitis B. Am J Pathol (1975) 1.64
Distribution of five antigens in hepatocellular carcinoma. Lab Invest (1979) 1.35
Immunofluorescence microscopy in experimentally induced, type B hepatitis in the chimpanzee. Gastroenterology (1978) 1.13
The pathology of viral hepatitis types A and B in chimpanzees. A comparison. Am J Pathol (1976) 1.13
Prevalence of hepatitis B e antigen and its antibody as detected by radioimmunoassays. J Med Virol (1978) 1.08
Integrator enzyme hypothesis for replication of hepatitis-B virus. Lancet (1975) 1.06
The pathology of viral hepatitis in chimpanzees. Virchows Arch A Pathol Anat Histol (1980) 0.99
Two distinct types of hepatitis in experimental hepatitis B virus infection. Am J Pathol (1980) 0.83
Immunopathologic aspects of the HBsAg carrier state in chimpanzees. J Med Primatol (1979) 0.83
Antibodies to ribosomes in chronic active hepatitis. Gastroenterology (1979) 12.78
The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med (1992) 9.10
A classification of chronic hepatitis. Lancet (1968) 6.07
Disseminated Kaposi's sarcoma in homosexual men. Ann Intern Med (1982) 4.98
Diagnosis and management of infective endocarditis and its complications. Circulation (1999) 4.77
Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. N Engl J Med (1991) 4.68
Non-A, non-B hepatitis in chimpanzees and marmosets. J Infect Dis (1981) 4.15
A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children. N Engl J Med (1992) 4.05
Immunodeficiency in female sexual partners of men with the acquired immunodeficiency syndrome. N Engl J Med (1983) 3.67
A controlled trial of antimicrobial prophylaxis for Lyme disease after deer-tick bites. N Engl J Med (1992) 3.65
Opportunistic infections and immune deficiency in homosexual men. Ann Intern Med (1982) 3.29
Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus. Proc Natl Acad Sci U S A (1991) 3.22
Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant. Proc Natl Acad Sci U S A (1995) 3.20
Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies and post-mortem tissue specimens. N Engl J Med (1981) 3.17
Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab (1999) 3.00
Long-term outcomes of persons with Lyme disease. JAMA (2000) 2.96
The canals of Hering and hepatic stem cells in humans. Hepatology (1999) 2.93
Transmission of the hepatitis B virus-associated delta agent to the eastern woodchuck. Proc Natl Acad Sci U S A (1984) 2.87
European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis. Eur Respir J (2010) 2.86
Transmissible agent in non-A, non-B hepatitis. Lancet (1978) 2.78
Identification of integrated hepatitis B virus DNA and expression of viral RNA in an HBsAg-producing human hepatocellular carcinoma cell line. Nature (1980) 2.72
Lymphocyte stimulation induced by halothane in patients with hepatitis following exposure to halothane. N Engl J Med (1970) 2.71
Hepatocyte proliferation in vitro: its dependence on the use of serum-free hormonally defined medium and substrata of extracellular matrix. Proc Natl Acad Sci U S A (1984) 2.64
Long-term, near-total liver replacement by transplantation of isolated hepatocytes in rats treated with retrorsine. Am J Pathol (1998) 2.62
Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA (1990) 2.61
Isolation and partial characterization of reticulocyte factors M1 and M2. J Biol Chem (1970) 2.59
Diagnosis and management of group A streptococcal pharyngitis: a practice guideline. Infectious Diseases Society of America. Clin Infect Dis (1997) 2.54
Hepatic angiomyolipoma: a clinicopathologic study of 30 cases and delineation of unusual morphologic variants. Am J Surg Pathol (1999) 2.53
Fast skeletal muscle myosin light chains 1 and 3 are produced from a single gene by a combined process of differential RNA transcription and splicing. J Biol Chem (1984) 2.49
Hepatitis B virus produced by transfected Hep G2 cells causes hepatitis in chimpanzees. Proc Natl Acad Sci U S A (1987) 2.46
Experimental infection of chimpanzees with hepatitis A virus. J Infect Dis (1975) 2.41
Studies on the transmission of human viral hepatitis to marmoset monkeys. I. Transmission of disease, serial passages, and description of liver lesions. J Exp Med (1967) 2.41
Analysis of liver disease, nuclear HBcAg, viral replication, and hepatitis B virus DNA in liver and serum of HBeAg Vs. anti-HBe positive carriers of hepatitis B virus. Hepatology (1983) 2.36
Prevention of Bacterial Endocarditis. A statement for health professionals by the Committee on Rheumatic Fever and Infective Endocarditis of the Council on Cardiovascular Disease in the Young. Circulation (1984) 2.33
Diagnosis and therapy of Kawasaki disease in children. Circulation (1993) 2.32
Acquired immunodeficiency with reversed T4/T8 ratios in infants born to promiscuous and drug-addicted mothers. JAMA (1983) 2.29
Factors for the initiation of haemoglobin synthesis by rabbit reticulocyte ribosomes. Nature (1970) 2.27
Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice. Proc Natl Acad Sci U S A (1987) 2.24
Programmed cell death and AIDS: significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections. Proc Natl Acad Sci U S A (1994) 2.21
Hepatitis B virus DNA contains a glucocorticoid-responsive element. Proc Natl Acad Sci U S A (1986) 2.18
Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment. Ann Intern Med (1983) 2.16
Thymosin treatment of chronic hepatitis B: a placebo-controlled pilot trial. Hepatology (1991) 2.15
Hepatic fibrosis. Correlation of biochemical and morphologic investigations. Am J Med (1970) 2.12
Detection of hepatitis B virus DNA directly in human serum by a simplified molecular hybridization test: comparison to HBeAg/anti-HBe status in HBsAg carriers. Hepatology (1983) 2.10
Evidence for role of m7G5'-phosphate group in recognition of eukaryotic mRNA by initiation factor IF-M3. Nature (1976) 2.09
Comfrey herb tea-induced hepatic veno-occlusive disease. Am J Med (1989) 2.09
HMB-45 reactivity in adrenal pheochromocytomas. Arch Pathol Lab Med (1992) 2.03
Vitamin A-containing lipocytes and formation of type III collagen in liver injury. Proc Natl Acad Sci U S A (1976) 2.02
Fulminant hepatic failure. Presumable contribution to halothane. N Engl J Med (1968) 1.99
Alpha-tropomyosin gene organization. Alternative splicing of duplicated isotype-specific exons accounts for the production of smooth and striated muscle isoforms. J Biol Chem (1987) 1.96
Hepatitis after exposure to halothane. Ann Intern Med (1969) 1.95
Chronic type B hepatitis and the "healthy" HBsAg carrier state. Hepatology (1987) 1.94
Hepatocarcinogenicity of the woodchuck hepatitis virus. Proc Natl Acad Sci U S A (1987) 1.93
The aetiological agent of cat scratch disease. Lancet (1985) 1.93
High viral load in lymph nodes and latent human immunodeficiency virus (HIV) in peripheral blood cells of HIV-1-infected chimpanzees. J Virol (1993) 1.93
Vinyl-chloride-induced liver disease. From idiopathic portal hypertension (Banti's syndrome) to Angiosarcomas. N Engl J Med (1975) 1.92
Development of hepatic angiosarcoma in man induced by vinyl chloride, thorotrast, and arsenic. Comparison with cases of unknown etiology. Am J Pathol (1978) 1.92
A characterization of globin mRNA sequences in the nucleus of duck immature red blood cells. Cell (1977) 1.89
Antigen detection test for streptococcal pharyngitis: evaluation of sensitivity with respect to true infections. J Pediatr (1986) 1.89
The preoperative radiographic demonstration of intra-abdominal bleeding from undetermined sites by percutaneous selective celiac and superior mesenteric arteriography. Surgery (1965) 1.88
Activation, proliferation, and differentiation of progenitor cells into hepatocytes in the D-galactosamine model of liver regeneration. Am J Pathol (1993) 1.88
Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial. Gastroenterology (1985) 1.86
The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis. Hepatology (1992) 1.85
Identification of bipotential progenitor cells in human liver development. Hepatology (1996) 1.84
Evidence for supercoiled hepatitis B virus DNA in chimpanzee liver and serum Dane particles: possible implications in persistent HBV infection. Cell (1982) 1.81
Micronitrous acid extraction-coagglutination test for rapid diagnosis of streptococcal pharyngitis. J Clin Microbiol (1983) 1.79
Comparison of warfarin, low-molecular-weight dextran, aspirin, and subcutaneous heparin in prevention of venous thromboembolism following total hip replacement. J Bone Joint Surg Am (1974) 1.78
Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: a multicenter trial. Hepatology (1997) 1.77
Scintigraphic detection of acute gastrointestinal bleeding. Radiology (1977) 1.77
Control of portal hypertension by selective mesenteric arterial drug infusion. Arch Surg (1968) 1.74
Is prevaccination screening for hepatitis B among sexually active adolescents cost-effective? Clin Infect Dis (1998) 1.74
Delta virus infection and severe hepatitis. An epidemic in the Yucpa Indians of Venezuela. Ann Intern Med (1984) 1.74
Aneurysms secondary to pancreatitis. AJR Am J Roentgenol (1976) 1.73
Effect of antibiotic therapy on the clinical course of streptococcal pharyngitis. J Pediatr (1985) 1.73
Hepatic 'stem cell' malignancies in adults: four cases. Histopathology (2003) 1.73
Identification of integrated hepatitis B virus DNA sequences in human hepatocellular carcinomas. Hepatology (1981) 1.73
The control of gastrointestinal hemorrhage by selective mesenteric arterial infusion of vasopressin. Radiology (1971) 1.72
A novel, glycan-dependent epitope in the V2 domain of human immunodeficiency virus type 1 gp120 is recognized by a highly potent, neutralizing chimpanzee monoclonal antibody. J Virol (1994) 1.72
Vaccine protection of chimpanzees against challenge with HIV-1-infected peripheral blood mononuclear cells. Science (1992) 1.71
Electron microscopy and immunoelectronmicroscopy of cytoplasmic hepatitis B antigen in hepatocytes. Am J Pathol (1974) 1.70
Woodchuck hepatitis and hepatocellular carcinoma: correlation of histologic with virologic observations. Hepatology (1981) 1.67
Cytoplasmic hepatitis B antigen in "ground-glass" hepatocytes of carriers. Arch Pathol (1973) 1.65
Antimitochondrial antibodies in jaundice following drug administration. JAMA (1969) 1.61
Comparison of epidemic and endemic group G streptococci by restriction enzyme analysis. J Clin Microbiol (1990) 1.60
Telomerase activity in precancerous hepatic nodules. Cancer (1998) 1.59
Clinical experience with the diagnosis and management of gastrointestinal hemorrhage by selective mesenteric catheterization. Ann Surg (1969) 1.58
Angiodysplasia of the right colon: a cause of gastrointestinal bleeding. AJR Am J Roentgenol (1977) 1.58
Unusual ribosomal RNA of the intestinal parasite Giardia lamblia. Nucleic Acids Res (1987) 1.58
Hepatitis C virus-specific CTL responses in the liver of chimpanzees with acute and chronic hepatitis C. J Immunol (1993) 1.57
Latex agglutination tests for rapid identification of group A streptococci directly from throat swabs. J Pediatr (1984) 1.56